210 related articles for article (PubMed ID: 33621209)
1. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.
Traum D; Wang YJ; Schwarz KB; Schug J; Wong DK; Janssen H; Terrault NA; Khalili M; Wahed AS; Murray KF; Rosenthal P; Ling SC; Rodriguez-Baez N; Sterling RK; Lau DT; Block TM; Feldman MD; Furth EE; Lee WM; Kleiner DE; Lok AS; Kaestner KH; Chang KM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33621209
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
[TBL] [Abstract][Full Text] [Related]
3. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.
Wu JF; Chang MH
J Biomed Sci; 2015 Oct; 22():92. PubMed ID: 26487087
[TBL] [Abstract][Full Text] [Related]
4. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2019; 10():112. PubMed ID: 30778353
[No Abstract] [Full Text] [Related]
5. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
[TBL] [Abstract][Full Text] [Related]
6. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.
Huang YH; Hung HH; Chan CC; Lai CR; Chu CJ; Huo TI; Lee PC; Su CW; Lan KH; Huang HC; Lee IC; Lin HC; Lee SD
Clin Vaccine Immunol; 2010 Jun; 17(6):1048-53. PubMed ID: 20427626
[TBL] [Abstract][Full Text] [Related]
7. Influence of age and HBeAg status on the correlation between HBV DNA and hepatic inflammation and fibrosis in chronic hepatitis B patients.
Bai H; Liu H; Chen X; Xu C; Dou X
Dig Dis Sci; 2013 May; 58(5):1355-62. PubMed ID: 23179154
[TBL] [Abstract][Full Text] [Related]
8. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
Li TY; Yang Y; Zhou G; Tu ZK
World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
[TBL] [Abstract][Full Text] [Related]
9. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
10. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
12. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
Bayram A; Erkilic S; Ozkur A; Bayram M; Sari I
J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
[TBL] [Abstract][Full Text] [Related]
13. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
[TBL] [Abstract][Full Text] [Related]
14. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
[TBL] [Abstract][Full Text] [Related]
15. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
16. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
17. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.
Chang JJ; Thompson AJ; Visvanathan K; Kent SJ; Cameron PU; Wightman F; Desmond P; Locarnini SA; Lewin SR
Hepatology; 2007 Nov; 46(5):1332-40. PubMed ID: 17924445
[TBL] [Abstract][Full Text] [Related]
18. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
[TBL] [Abstract][Full Text] [Related]
19. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage.
Giadans CG; Ríos DA; Ameigeiras B; Pietrantonio AM; Lucatelli NL; Haddad L; Mullen E; Heinrich F; De Matteo E; Flichman D; Valva P; Preciado MV
J Viral Hepat; 2019 Jun; 26(6):727-737. PubMed ID: 30739377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
